Typhoid vaccine oral - Prokarium

Drug Profile

Typhoid vaccine oral - Prokarium

Alternative Names: M01ZH09; MICRO-TY; Salmonella typhi oral vaccine - Emergent BioSolutions; Typhella

Latest Information Update: 10 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Emergent BioSolutions
  • Developer Emergent BioSolutions; Prokarium
  • Class Bacterial vaccines; Drug conjugates
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Typhoid

Most Recent Events

  • 30 Jan 2009 Emergent BioSolutions completes a phase II trial in Typhoid prevention in USA
  • 09 Jan 2008 Final immunogenicity and adverse events data from a Phase-II trial in Typhoid prevention released by Emergent BioSolutions
  • 11 Oct 2007 Clinical data added to the adverse events and Bacterial Infections immunogenicity sections
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top